Verition Fund Management LLC Bio N Tech Se Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$126.25 - $231.85 $112,867 - $207,273
-894 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$216.64 - $362.52 $1.2 Million - $2.02 Million
-5,562 Reduced 86.15%
894 $230,000
Q4 2020

Feb 16, 2021
BUY
$72.71 - $129.54 $469,415 - $836,310
6,456 New
6,456 $526,000

Others Institutions Holding BNTX

# of Institutions
363
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email